Previous 10 | Next 10 |
Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it has started shipping its synthetic RNA reference controls for the SARS-CoV-2 Delta (B.1.617.2) and ...
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2021 third quarter ended June 30, 2021, before mark...
Are These The Best Synthetic Biology Stocks To Buy Right Now? As we begin another week of trading, investors would be looking for good stocks to invest in. If anything, emerging sectors of the stock market such as synthetic biology (SB) stocks could be worth considering now. Bef...
gguy44/iStock via Getty Images Piper Sandler Technical Market Strategist Craig. W. Johnson issued his July Alpha Alignment Report, which screens 900 stocks for a host of fundamental and technical factors. Along with the headline Alpha Alignment Index, the report also screens for an equal-weig...
These July selections are the current top positive and negative forensic stocks based on combined scores from four different forensic algorithms. The past 5 Negative Forensic portfolios have returned: Jan 2021 +16.7%, July 2020: +114.1%, Feb 2020: +64.9%, Dec 2019: +59.0%, Oct 2019: +...
Twist Bioscience (TWST) announces the acquisition of iGenomX, a company offering multiplex library preparation tools for next-generation sequencing ((NGS)) workflows. The total purchase consideration was $35M, including an initial $500,000 cash payment and $29.5M in Twist stock, as well as a ...
-- Accelerates Conversion from Microarray to Genotyping by Sequencing– -- Expands NGS Capabilities into New Markets -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using...
naphtalina/iStock via Getty Images Twist Bioscience ([[TWST]] +6.7%) looks set to continue its six-day winning streak today, and the stock seems on course to reach its highest level since late April with a new bullish call on Wall Street. William Blair has initiated the coverage of the stock ...
Twist Bioscience has come across my desk several times over the past couple of years, but I have always found an excuse to push it to the side. Twist offers some impressive products and services that could generate billions of dollars a year in revenue. The market is convinced and is ...
Dovetail Genomics Announces New Capture Hi-C Targeted Enrichment Panels PR Newswire SCOTTS VALLEY, Calif. , June 16, 2021 /PRNewswire/ -- Dovetail Genomics, the industry leader in advanced proximity ligation genomic solutions, today announced availabili...
News, Short Squeeze, Breakout and More Instantly...
Twist Bioscience Corporation Company Name:
TWST Stock Symbol:
NASDAQ Market:
Twist Bioscience Corporation Website:
Pure Biologics’ exploratory Phase 0 study to evaluate pharmacodynamic activity of PBA-0405 in solid tumors Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today a...
Company to host conference call at 8:00 AM ET Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it will issue its financial results for the fiscal 2024 th...
Express Genes enable faster turnaround times Twist Express Antibodies, CHO starting at 13 business days Twist Express Antibodies, HEK293 starting at 10 business days Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of ...